A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90 yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma
Witzig, Thomas E., Wiseman, Gregory A., Maurer, Matthew J., Habermann, Thomas M., Micallef, Ivana N.M., Nowakowski, Grzegorz S., Ansell, Stephen M., Colgan, Joseph P., Inwards, David J., Porrata, LuisТом:
88
Мова:
english
Журнал:
American Journal of Hematology
DOI:
10.1002/ajh.23460
Date:
July, 2013
Файл:
PDF, 158 KB
english, 2013